Arquestra

Arquestra › Tenders › Germany › Research & evaluation

Open tender

Cro penelope study · Charité - Universitätsmedizin Berlin

Bid deadline3 Dec 2026
Valuenot published
BuyerCharité - Universitätsmedizin BerlinGermany
Kind of workResearch & evaluation

In short

Charité – Universitätsmedizin Berlin wants a clinical research organisation (CRO) to carry out the PENELOPE study, under a single-supplier framework that runs 72 months. Bidders need 3 comparable references in thoracic oncology trials of at least 80 participants and 3 years. Separate requirements under the Berlin tendering law apply. Tenders in German.

Summary of the notice; the official notice prevails.

Official title (DE): «CRO PENELOPE-Studie» · machine translation of the original title

At a glance

Who can bid
Clinical research organisations with 3 references from the last 5 years in thoracic-oncology trials (at least 80 participants and 3 years each).
Who it suits
It suits a clinical research organisation with thoracic-oncology trial experience, working in German. (a reading of the notice, not a requirement)
What wins
Quality 70% (project lead qualification and experience 35%, implementation concept 35%), price 30%
Contract
One firm, framework agreement, 72 months
Language
Tenders in German only
Deadline
3 Dec 2026, 11:00 Berlin time
The documents appear on the portal only about three days after dispatch to the EU journal.
Value
Not published by the buyer; for comparison, advisory and studies contracts in Germany: half were awarded between €216 k and €691 k, median €350 k (471 awards with a published value, Nov 2024 to Nov 2026).
Documents and bids
vergabeplattform.charite.de · registration not required
Open the official notice ↗

What this means

Quality weighs 70%: the project lead's experience and the implementation concept carry 35% each, more than the price at 30%. These contracts in Germany were awarded at a median of €349 k, half between €213 k and €677 k (446 awards). Three references in thoracic oncology are required: a very specific requirement.

A reading of the notice and the radar's data; not advice.

What to check before you bid

  • Deadline: 3 Dec 2026, 11:00 Berlin time
  • Questions deadline: Questions go only through the Charité bidder portal.
    In the notice

    «Ihre Fragen/Hinweise reichen Sie bitte ebenfalls nur über https://vergabeplattform.charite.de ein.»

  • Turnover and references asked: 3 company references from the last 5 years, each in thoracic oncology with at least 80 participants in interventional randomised trials and a study duration of at least 3 years.
    In the notice

    «Nachzuweisen sind 3 Unternehmensreferenzen über ausgeführte vergleichbare Leistungen, welche folgende Merkmale erfüllen müssen»

  • Award criteria: Price 30%, project lead qualification and experience 35%, implementation concept 35%.
    In the notice

    Niedrigster Preis 30% · Qualifikation und Erfahrung des Projektleiters 35% · Qualität der zu erwartenden Leistung - Umsetzungskonzept 35%

  • Documents: On the buyer's portal (vergabeplattform.charite.de); registration not required.
    In the notice

    «Die Vergabeunterlagen stehen ausschließlich auf unserem Bieterportal zum Download zur Verfügung. Eine Registrierung ist nicht erforderlich, wird jedoch empfohlen»

  • Submission: Electronic bids only; no signature or additional software is needed. Bids go through the same portal (vergabeplattform.charite.de).
    In the notice

    «Es sind nur elektronische Angebote zugelassen. Signatur und Zusatzsoftware werden nicht benötigt.»

In the documents, look first for: lots, consortia and subcontracting.

Also in this notice:

  • Framework agreement with a single firm.
  • One bidder may submit more than one tender.
  • Not marked as suitable for SMEs.
  • Tenders in German only.
  • Tenders must remain valid for 18 days.
  • No variants.
  • The documents appear on the portal only about three days after dispatch to the EU journal.
    In the notice

    «Bitte beachten Sie, dass die Ausschreibungsunterlagen erst ca. drei Tage nach der Weiterleitung»

  • Separate requirements under the Berlin tendering and procurement law (BerlAVG) are set out in the documents.
    In the notice

    «Es bestehen gesonderte Anforderungen nach dem Berliner Ausschreibungs- und Vergabegesetz (BerlAVG), siehe Vergabeunterlagen.»

Read from the notice; each point quotes its words. The official notice and procurement documents prevail.

Notice details
CPV
73000000
Published
4 Nov 2026
Source
TED (the EU's Official Journal)
Official notice
ted.europa.eu ↗

What does this kind of work look like in Germany?

Market figures

Research & evaluation: 756 awards, 315 with a published value; median value €319 k (half between €210 k and €670 k); median 3 bids; a single bid in 27% of 553 with a bid count.

Advisory and studies in Germany: 1,361 awards, 471 with a published value; median value €350 k; median 3 bids; a single bid in 23% of 988 with a bid count.

SMEs win 64% of the 972 awards that give the winner's size.

Median weight of price in the award criteria: 40% (705 awards with published criteria).

Is this worth bidding for you?

A quick read from the radar's data: what is known about the value, the competition and the buyer. Not a recommendation. Computed from the awards of the last 24 months only (20 Nov 2024 to 19 Nov 2026); each figure gives its base.

Competition
typically 3 bids per lot; 27% of lots had a single bid (552 awards, 553 lots: research & evaluation in Germany)
Who this buyer usually picks
Zentrum für Klinische Studien Leipzig, Labor LS SE & Co. KG, nk consulting GmbH: together 50% of its 6 awards with a named winner
Does it change supplier?
It changes supplier: none of its last 5 awards after the first went to a firm that had won from it before
Who wins this kind of work in Germany
Prognos AG (12 awards) · forsa Gesellschaft für Sozialforschung und statistische Analysen mbH (10 awards) · Verian (8 awards) · Deloitte (8 awards) · Ipsos (8 awards) · research & evaluation in Germany

In 553 lots of comparable awards the usual number of bids was 3 (the median). With yours there are 4, so an average bid wins 1 in 4 (25%). No value published: the typical comparable award, €318,634 (the middle value of 315 comparable awards). Expected fees: 25% × €318,634 = €79,659. Your margin, the share of the fee that is profit for you, turns the expected fees into what a bid is worth: none is assumed.

Open this call in the radar's "Does it pay" view →

The radar compares with a narrower set of awards, so its figure can differ.

What has this buyer awarded before?

6 consulting awards in 24 months; 4 are for similar work (advisory and studies; small base).

The 4 awards for similar work
DateContractWon byValueBids
19 Aug 2026Studie CRO LEMOZentrum für Klinische Studien Leipzig—2
2 Mar 2026Durchführung von GMP-gerechten SpezialanalysenLabor LS SE & Co. KG—1
18 Dec 2025Studie CRO OBERTO-202Frankfurter Institut für Klinische Krebsforschung IKF—1
11 Apr 2025Studie CRO FOLFIRINOX-SBA FIRE-12Institut für Klinische Krebsforschung IKF GmbH—1

Similar open tenders from other buyers

No open tender from another buyer is close to this one in content right now.

More open calls for advisory and studies in Germany

Same country and kind of work, by deadline; not chosen by similarity.

Market page: strategy & advisory in Germany

Where to go next

research & evaluation tenders in GermanyAll open tenders in this selection

Data of 19 Nov 2026, updated every week from TED and national registers. Licence CC BY 4.0: cite “Source: Arquestra Consulting Market Radar (arquestra.dev), built from TED and national procurement registers”.

Who is writing

Pablo Ramos-Sánchez builds the Arquestra Consulting Market Radar: which public consulting tenders are open in Europe and who usually wins them. · Write to me at [email protected]